117 related articles for article (PubMed ID: 10928312)
1. Methoclocinnamox: time course of changes in alfentanil-reinforced responding in rhesus monkeys.
Briscoe RJ; Winger G; Lewis JW; Woods JH
Psychopharmacology (Berl); 2000 Mar; 148(4):393-9. PubMed ID: 10928312
[TBL] [Abstract][Full Text] [Related]
2. Buprenorphine and methoclocinnamox: agonist and antagonist effects on respiratory function in rhesus monkeys.
Kishioka S; Paronis CA; Lewis JW; Woods JH
Eur J Pharmacol; 2000 Mar; 391(3):289-97. PubMed ID: 10729371
[TBL] [Abstract][Full Text] [Related]
3. Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys.
Winger G; Skjoldager P; Woods JH
J Pharmacol Exp Ther; 1992 Apr; 261(1):311-7. PubMed ID: 1560376
[TBL] [Abstract][Full Text] [Related]
4. Clocinnamox inhibits the intravenous self-administration of opioid agonists in rhesus monkeys: comparison with effects on opioid agonist-mediated antinociception.
Zernig G; Lewis JW; Woods JH
Psychopharmacology (Berl); 1997 Feb; 129(3):233-42. PubMed ID: 9084061
[TBL] [Abstract][Full Text] [Related]
5. Methoclocinnamox: agonist and antagonist effects of a novel long-lasting opioid in rhesus monkeys.
Butelman ER; Lewis JW; Woods JH
J Pharmacol Exp Ther; 1996 Nov; 279(2):934-8. PubMed ID: 8930202
[TBL] [Abstract][Full Text] [Related]
6. Clocinnamox antagonism of the antinociceptive effects of mu opioids in squirrel monkeys.
Pitts RC; Allen RM; Walker EA; Dykstra LA
J Pharmacol Exp Ther; 1998 Jun; 285(3):1197-206. PubMed ID: 9618423
[TBL] [Abstract][Full Text] [Related]
7. Long-Lasting Effects of Methocinnamox on Opioid Self-Administration in Rhesus Monkeys.
Maguire DR; Gerak LR; Woods JH; Husbands SM; Disney A; France CP
J Pharmacol Exp Ther; 2019 Jan; 368(1):88-99. PubMed ID: 30401680
[TBL] [Abstract][Full Text] [Related]
8. In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox.
Zernig G; Butelman ER; Lewis JW; Walker EA; Woods JH
J Pharmacol Exp Ther; 1994 Apr; 269(1):57-65. PubMed ID: 8169852
[TBL] [Abstract][Full Text] [Related]
9. Clocinnamox antagonism of opioid suppression of schedule-controlled responding in rhesus monkeys.
Butelman ER; Negus SS; Lewis JW; Woods JH
Psychopharmacology (Berl); 1996 Feb; 123(4):320-4. PubMed ID: 8867870
[TBL] [Abstract][Full Text] [Related]
10. Clocinnamox distinguishes opioid agonists according to relative efficacy in normal and morphine-treated rats trained to discriminate morphine.
Walker EA; Young AM
J Pharmacol Exp Ther; 2002 Jul; 302(1):101-10. PubMed ID: 12065706
[TBL] [Abstract][Full Text] [Related]
11. 3-Alkyl ethers of clocinnamox: delayed long-term mu-antagonists with variable mu efficacy.
Husbands SM; Sadd J; Broadbear JH; Woods JH; Martin J; Traynor JR; Aceto MD; Bowman ER; Harris LS; Lewis JW
J Med Chem; 1998 Aug; 41(18):3493-8. PubMed ID: 9719602
[TBL] [Abstract][Full Text] [Related]
12. Effects of mu-opioid agonists on cocaine- and food-maintained responding and cocaine discrimination in rhesus monkeys: role of mu-agonist efficacy.
Negus SS; Mello NK
J Pharmacol Exp Ther; 2002 Mar; 300(3):1111-21. PubMed ID: 11861822
[TBL] [Abstract][Full Text] [Related]
13. Methocinnamox (MCAM) antagonizes the behavioral suppressant effects of morphine without impairing delayed matching-to-sample accuracy in rhesus monkeys.
Minervini V; Disney A; Husbands SM; France CP
Psychopharmacology (Berl); 2020 Oct; 237(10):3057-3065. PubMed ID: 32772146
[TBL] [Abstract][Full Text] [Related]
14. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
[TBL] [Abstract][Full Text] [Related]
15. The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys.
Winger G; Woods JH
Drug Alcohol Depend; 2001 May; 62(3):181-9. PubMed ID: 11295322
[TBL] [Abstract][Full Text] [Related]
16. Reinforcing effect of alfentanil is mediated by mu opioid receptors: apparent pA2 analysis.
Bertalmio AJ; Woods JH
J Pharmacol Exp Ther; 1989 Nov; 251(2):455-60. PubMed ID: 2553919
[TBL] [Abstract][Full Text] [Related]
17. Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of
Gerak LR; Minervini V; Latham E; Ghodrati S; Lillis KV; Wooden J; Disney A; Husbands SM; France CP
J Pharmacol Exp Ther; 2019 Nov; 371(2):507-516. PubMed ID: 31439807
[TBL] [Abstract][Full Text] [Related]
18. Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: in vivo and in vitro characterization of mu-selective agonist and antagonist activity.
McLaughlin JP; Hill KP; Jiang Q; Sebastian A; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1999 Apr; 289(1):304-11. PubMed ID: 10087018
[TBL] [Abstract][Full Text] [Related]
19. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS
Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442
[TBL] [Abstract][Full Text] [Related]
20. Effects of Daily Methocinnamox Treatment on Fentanyl Self-Administration in Rhesus Monkeys.
Maguire DR; France CP
J Pharmacol Exp Ther; 2022 Aug; 382(2):181-187. PubMed ID: 35643857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
